Indegene Ltd IPO

Domain expertise in healthcare.

Robust digital capabilities and in-house developed technology portfolio.

Track record of establishing long-standing client relationships.

Global delivery model.

Experienced management and motivated talent pool supported by marquee investors.

Track record of creating value through acquisitions.

Its business is solely focused on the life sciences industry and may be adversely impacted by factors affecting the life sciences industry, including the growth of the overall life sciences industry, outsourcing and other trends.

As its business is solely focused on the life sciences industry and a significant portion of its business is attributable to certain large clients located in North America and Europe, its business and profitability is dependent on factors affecting the life sciences industry and the company continuing relationships with such key clients.

Its business and revenue models may be unfamiliar to prospective investors.

The majority of its revenues are derived from the company Subsidiaries. Any disruptions in the operations of one or more of its Subsidiaries may adversely affect its business, financial condition, results of operations.

The company proposes to utilize approximately 52.41% of the Net Proceeds by way of investments in its Subsidiaries by way of debt, towards identified objects of the Offer. The use of such funds will be subject to the laws of the countries in which its Subsidiaries are incorporated, and the company may have limited control over the manner in which such funds are utilized.

The life sciences operations industry is highly competitive, and it is difficult to predict its future prospects.

Its business continuity and disaster recovery plans may be inadequate. If any disruption that the company has not contemplated in its business continuity and disaster recovery plans occurs or if the company is unable to ensure that key services are resumed within agreed timelines, its business, financial condition and results of operations may be adversely affected.

There may be delays in timing of revenue recognition which may cause its margins to fluctuate.

If the company is unable to manage attrition and attract and retain skilled professionals, it may have an adverse impact on its business prospects, reputation and future financial performance.

If the company underprice its work orders, overrun its cost estimates, or fail to receive approval for or experience delays in documentation of change orders, its business, financial condition, results of operations, or cash flows may be adversely affected.